A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer
Abstract Safe and noninvasive methods for breast cancer screening with improved accuracy are urgently needed. Volatile organic compounds (VOCs) in biological samples such as breath and blood have been investigated as noninvasive novel markers of cancer. We investigated volatile organic compounds in...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2021-10-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-021-99396-5 |
| _version_ | 1818343137073954816 |
|---|---|
| author | Shoko Kure Sera Satoi Toshihiko Kitayama Yuta Nagase Nobuo Nakano Marina Yamada Noboru Uchiyama Satoshi Miyashita Shinya Iida Hiroyuki Takei Masao Miyashita |
| author_facet | Shoko Kure Sera Satoi Toshihiko Kitayama Yuta Nagase Nobuo Nakano Marina Yamada Noboru Uchiyama Satoshi Miyashita Shinya Iida Hiroyuki Takei Masao Miyashita |
| author_sort | Shoko Kure |
| collection | DOAJ |
| description | Abstract Safe and noninvasive methods for breast cancer screening with improved accuracy are urgently needed. Volatile organic compounds (VOCs) in biological samples such as breath and blood have been investigated as noninvasive novel markers of cancer. We investigated volatile organic compounds in urine to assess their potential for the detection of breast cancer. One hundred and ten women with biopsy-proven breast cancer and 177 healthy volunteers were enrolled. The subjects were divided into two groups: a training set and an external validation set. Urine samples were collected and analyzed by gas chromatography and mass spectrometry. A predictive model was constructed by multivariate analysis, and the sensitivity and specificity of the model were confirmed using both a training set and an external set with reproducibility tests. The training set included 60 breast cancer patients (age 34–88 years, mean 60.3) and 60 healthy controls (age 34–81 years, mean 58.7). The external validation set included 50 breast cancer patients (age 35–85 years, mean 58.8) and 117 healthy controls (age 18–84 years, mean 51.2). One hundred and ninety-one compounds detected in at least 80% of the samples from the training set were used for further analysis. The predictive model that best-detected breast cancer at various clinical stages was constructed using a combination of two of the compounds, 2-propanol and 2-butanone. The sensitivity and specificity in the training set were 93.3% and 83.3%, respectively. Triplicated reproducibility tests were performed by randomly choosing ten samples from each group, and the results showed a matching rate of 100% for the breast cancer patient group and 90% for the healthy control group. Our prediction model using two VOCs is a useful complement to the current diagnostic tools. Further studies inclusive of benign tumors and non-breast malignancies are warranted. |
| first_indexed | 2024-12-13T16:25:48Z |
| format | Article |
| id | doaj.art-5b74586ff87a40af8f9e5238cdd41996 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-13T16:25:48Z |
| publishDate | 2021-10-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-5b74586ff87a40af8f9e5238cdd419962022-12-21T23:38:36ZengNature PortfolioScientific Reports2045-23222021-10-0111111310.1038/s41598-021-99396-5A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancerShoko Kure0Sera Satoi1Toshihiko Kitayama2Yuta Nagase3Nobuo Nakano4Marina Yamada5Noboru Uchiyama6Satoshi Miyashita7Shinya Iida8Hiroyuki Takei9Masao Miyashita10Department of Integrated Diagnostic Pathology, Nippon Medical SchoolDepartment of Medicine, Mount Sinai Beth IsraelRIKEN KEIKI Co., Ltd.RIKEN KEIKI Co., Ltd.RIKEN KEIKI Co., Ltd.Faculty of Medical Science, Nippon Sport Science UniversityKoyukai Asakusa ClinicDepartment of Cardiovascular Medicine, Tufts Medical CenterDepartment of Breast Oncology, Nippon Medical School Chiba Hokusoh HospitalDepartment of Breast Surgery and Oncology, Nippon Medical School HospitalNippon Medical SchoolAbstract Safe and noninvasive methods for breast cancer screening with improved accuracy are urgently needed. Volatile organic compounds (VOCs) in biological samples such as breath and blood have been investigated as noninvasive novel markers of cancer. We investigated volatile organic compounds in urine to assess their potential for the detection of breast cancer. One hundred and ten women with biopsy-proven breast cancer and 177 healthy volunteers were enrolled. The subjects were divided into two groups: a training set and an external validation set. Urine samples were collected and analyzed by gas chromatography and mass spectrometry. A predictive model was constructed by multivariate analysis, and the sensitivity and specificity of the model were confirmed using both a training set and an external set with reproducibility tests. The training set included 60 breast cancer patients (age 34–88 years, mean 60.3) and 60 healthy controls (age 34–81 years, mean 58.7). The external validation set included 50 breast cancer patients (age 35–85 years, mean 58.8) and 117 healthy controls (age 18–84 years, mean 51.2). One hundred and ninety-one compounds detected in at least 80% of the samples from the training set were used for further analysis. The predictive model that best-detected breast cancer at various clinical stages was constructed using a combination of two of the compounds, 2-propanol and 2-butanone. The sensitivity and specificity in the training set were 93.3% and 83.3%, respectively. Triplicated reproducibility tests were performed by randomly choosing ten samples from each group, and the results showed a matching rate of 100% for the breast cancer patient group and 90% for the healthy control group. Our prediction model using two VOCs is a useful complement to the current diagnostic tools. Further studies inclusive of benign tumors and non-breast malignancies are warranted.https://doi.org/10.1038/s41598-021-99396-5 |
| spellingShingle | Shoko Kure Sera Satoi Toshihiko Kitayama Yuta Nagase Nobuo Nakano Marina Yamada Noboru Uchiyama Satoshi Miyashita Shinya Iida Hiroyuki Takei Masao Miyashita A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer Scientific Reports |
| title | A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer |
| title_full | A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer |
| title_fullStr | A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer |
| title_full_unstemmed | A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer |
| title_short | A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer |
| title_sort | prediction model using 2 propanol and 2 butanone in urine distinguishes breast cancer |
| url | https://doi.org/10.1038/s41598-021-99396-5 |
| work_keys_str_mv | AT shokokure apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT serasatoi apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT toshihikokitayama apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT yutanagase apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT nobuonakano apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT marinayamada apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT noboruuchiyama apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT satoshimiyashita apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT shinyaiida apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT hiroyukitakei apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT masaomiyashita apredictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT shokokure predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT serasatoi predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT toshihikokitayama predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT yutanagase predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT nobuonakano predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT marinayamada predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT noboruuchiyama predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT satoshimiyashita predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT shinyaiida predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT hiroyukitakei predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer AT masaomiyashita predictionmodelusing2propanoland2butanoneinurinedistinguishesbreastcancer |